Fast updates from the world of phages, viromes, and microbiome science.
PrecisionPhage has officially announced the opening of its post-seed funding round, marking a significant step toward scaling advanced genomic and bioinformatics solutions to tackle antimicrobial resistance…
In osteomyelitis cases, MRSA (Methicillin Resistant Staphylococcus aureus) is the most common pathogen associated. As the infection is deep-seated, treatment with antibiotics has always faced failures.…
Europe is taking a significant step towards bringing bacteriophage therapy closer to routine clinical use, with the creation of a new specialist group focused on how…
Experiments conducted aboard the International Space Station are revealing an unexpected ally in the fight against antimicrobial resistance: bacteriophages shaped by microgravity.New findings suggest that viruses…
The global healthcare landscape is witnessing a powerful resurgence of an old yet revolutionary concept—phage therapy. According to a new market intelligence report by InsightAce Analytic…
The 9th World Congress on Targeting Phage Therapy has been officially announced and will take place on June 11–12, 2026, in Valencia, Spain. This internationally recognized…
BiomX Inc. has announced the discontinuation of its Phase 2b clinical trial of BX004, a nebulized phage therapy under investigation for cystic fibrosis (CF) patients with…
The JAFRAL Phage Summit 2026 has officially unveiled its first event brochure, offering an early look at one of the most anticipated international meetings focused on…
In a quiet but significant moment for modern medicine, clinicians in Lyon, France, have treated their 100th patient using pharmaceutical-grade bacteriophage therapy, a milestone that reflects…
As the healthcare, veterinary, and biotechnology sectors are searching for effective alternatives to antibiotics in the fight against antimicrobial resistance (AMR), the global Phage Therapy Market…